Clinical impact of a 31-gene expression profile test for cutaneous melanoma in 156 prospectively and consecutively tested patients-Reference-Cited by-同舟云学术

Clinical impact of a 31-gene expression profile test for cutaneous melanoma in 156 prospectively and consecutively tested patients

Published:2016-06-03 Issue:9 Volume:32 Page:1599-1604
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Berger Adam C.¹,Davidson Robert S.²,Poitras J. Kevin³,Chabra Indy⁴,Hope Richard⁵,Brackeen Amy⁵,Johnson Clare E.⁶,Maetzold Derek J.⁶,Middlebrook Brooke⁶,Oelschlager Kristen M.⁶,Cook Robert W.⁶,Monzon Federico A.⁶,Miller Alexander R.⁷

Affiliation:

1. Thomas Jefferson University Hospital, Philadelphia, PA, USA;

2. Surgical Associates of West Florida, Safety Harbor, FL, USA;

3. Florida Medical Clinic, Land O Lakes, FL, USA;

4. Midlands Clinic, Dakota Dunes, SD, USA;

5. Lubbock Dermatology and Skin Cancer Center, Lubbock, TX, USA;

6. Castle Biosciences Inc., Friendswood, TX, USA;

7. Miller Start Center for Cancer Care, San Antonio, TX, USA

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2016.1192997

Reference24 articles.

1. Coit DG. NCCN Clinical Practice Guidelines in Oncology Melanoma Version 3.2015, in NCCN Clinical Practice Guidelines in Oncology. National Comprehensive Cancer Network, 2015

2. Final Version of 2009 AJCC Melanoma Staging and Classification

3. The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM

4. Discordance of histopathologic parameters in cutaneous melanoma: Clinical implications

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrating the 40-Gene Expression Profile (40-GEP) Test Improves Metastatic Risk-Stratification Within Clinically Relevant Subgroups of High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients;Dermatology and Therapy;2024-03

2. Sentinel lymph node assessment in melanoma: current state and future directions;Histopathology;2023-08

3. 31-Gene Expression Profile Testing in Cutaneous Melanoma and Survival Outcomes in a Population-Based Analysis: A SEER Collaboration;JCO Precision Oncology;2023-06

4. Incorporation of the 40-Gene Expression Profile (40-GEP) Test to Improve Treatment Decisions in High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients: Case Series and Algorithm;Clinical, Cosmetic and Investigational Dermatology;2023-04

5. The 31-gene expression profile test informs sentinel lymph node biopsy decisions in patients with cutaneous melanoma: results of a prospective, multicenter study;Current Medical Research and Opinion;2023-01-16